These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17471442)

  • 1. Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani.
    Barbi J; Oghumu S; Rosas LE; Carlson T; Lu B; Gerard C; Lezama-Davila CM; Satoskar AR
    J Infect Dis; 2007 Jun; 195(11):1713-7. PubMed ID: 17471442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
    Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
    Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
    Rosas LE; Barbi J; Lu B; Fujiwara Y; Gerard C; Sanders VM; Satoskar AR
    Eur J Immunol; 2005 Feb; 35(2):515-23. PubMed ID: 15668916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.
    Rosas LE; Satoskar AA; Roth KM; Keiser TL; Barbi J; Hunter C; de Sauvage FJ; Satoskar AR
    Am J Pathol; 2006 Jan; 168(1):158-69. PubMed ID: 16400019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.
    Sato N; Kuziel WA; Melby PC; Reddick RL; Kostecki V; Zhao W; Maeda N; Ahuja SK; Ahuja SS
    J Immunol; 1999 Nov; 163(10):5519-25. PubMed ID: 10553079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators.
    Matte C; Olivier M
    J Infect Dis; 2002 Mar; 185(5):673-81. PubMed ID: 11865425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
    Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
    J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
    Engwerda CR; Smelt SC; Kaye PM
    Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice.
    Alexander CE; Kaye PM; Engwerda CR
    Eur J Immunol; 2001 Apr; 31(4):1199-210. PubMed ID: 11298345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.
    Squires KE; Schreiber RD; McElrath MJ; Rubin BY; Anderson SL; Murray HW
    J Immunol; 1989 Dec; 143(12):4244-9. PubMed ID: 2512353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
    Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM
    Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
    Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic T cell-specific expression of CXCR3 enhances splenic and hepatic T cell accumulation but does not affect the outcome of visceral leishmaniasis.
    Varikuti S; Natarajan G; Oghumu S; Sperling RH; Moretti E; Stock J; Papenfuss TL; Satoskar AR
    Cell Immunol; 2016 Nov; 309():61-68. PubMed ID: 27614845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma Interferon-Regulated Chemokines in Leishmania donovani Infection in the Liver.
    Murray HW; Luster AD; Zheng H; Ma X
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27795366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance against Leishmania donovani induced with an aluminum hydroxide vaccine.
    Jarecki-Black JC; Hallman KL; James ER; Glassman AB
    Ann Clin Lab Sci; 1988; 18(1):72-7. PubMed ID: 3355098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rIL-2-stimulated splenocytes reactivate the NO2-producing ability of macrophages infected by Leishmania donovani.
    Eslami Z; Tanner CE
    Immunopharmacol Immunotoxicol; 2000 Aug; 22(3):465-87. PubMed ID: 10946826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani.
    Hassan MF; Zhang Y; Engwerda CR; Kaye PM; Sharp H; Bickle QD
    Am J Pathol; 2006 Sep; 169(3):943-53. PubMed ID: 16936268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis.
    Rezai HR; Farrell J; Soulsby EL
    Clin Exp Immunol; 1980 Jun; 40(3):508-14. PubMed ID: 6968259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.